show episodes
 
S
SAEM 2007 Satellite Symposium: Controversies in Emergency Cardiology, Round II
 
The Society for Academic Emergency Medicine's (SAEM) mission is to improve patient care by advancing research and education in emergency medicine. This satellite symposium, held during the 2007 SAEM annual meeting, features leaders in cardiac medicine debating on topics which include: the use of different antithrombotic therapies in treating ACS, natriuretic peptides, antiplatelet therapy, PCI, and lytic agents.
 
S
SAEM 2006 Annual Meeting Debate: Controversies in Emergency Cardiology
 
The Society for Academic Emergency Medicine's (SAEM) mission is to improve patient care by advancing research and education in emergency medicine. The 2006 SAEM annual meeting features leaders in cardiac medicine debating the use of numerous antithrombotic therapies in treating ACS, the use of ischemia markers, and invasive verus noninvasive hemodynamic monitoring.
 
Loading …
show series
 
Is there a role for fondaparinux in perioperative bridging? Author Candice Garwood discusses with Lori Justice, Associate Editor for AJHP, issues surrounding the use of fondaparinux as a bridging agent in the perioperative setting. The article under discussion appears in the January 1, 2011, issue of AJHP, and will also appear as an Ahead-of-Pr ...…
 
S
SAEM 2007 Satellite Symposium: Controversies in Emergency Cardiology, Round II
 
CEC debate on the efficacy, safety, and utility of fondaparinux versus LMWH compared with that of bivalirudin: Moderator: W. Frank Peacock IV, MD; Debaters: Chadwick D. Miller, MD versus Deborah B. Diercks, MD, FACEP.
 
C
ClinicalTrialResults.org Podcasts
 
CTR.org Ask the Experts program, a presentation by Ron J. G. Peters, MD regarding the efficacy and safety of fondaparinux in elderly patients with STEMI: data from the OASIS 6 trial.
 
C
Clinical Trial Results Podcasts
 
CTR Ask the Experts program, a presentation by C. Michael Gibson, MS, MD: The OASIS 5 and ACUITY clinical trials. Dr. Gibson presents the results from the OASIS V and ACUITY trials. Efficacy and safety data are presented for fondaparinux versus enoxaparin and for enoxaparin versus bivalirudin.
 
S
SAEM 2006 Annual Meeting Debate: Controversies in Emergency Cardiology
 
CEC Debate on the efficacy, safety and utility of fondaparinux versus LMWH: Moderator: James Hoekstra MD; Debaters: Charles V. Pollack Jr. MA MD versus Judd Hollander MD.
 
Speed
Series preference
1x
1x
Volume
100%
/

Google login Twitter login Classic login